Skip to main content

Medical Oncology

Ausgabe 8/2023

Inhalt (35 Artikel)

Original Paper

Hydrogen sulfide suppresses H2O2-induced proliferation and migration of HepG2 cells through Wnt/β-catenin signaling pathway

Hongzhi Zhao, Liang Zhao, Lin Wu, Sheng Hu, Yangmei Huang, Wei Zhao

Original Paper

FAK inhibitor PF-562271 inhibits the migration and proliferation of high-grade serous ovarian cancer cells through FAK and FAK mediated cell cycle arrest

Qionghui Pan, Qingyu Wang, Tianshu Zhao, Xinyu Zhao, Yixin Liang, Mengyun Shi, Cong Chen, Feng Lin

Original Paper

Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells

Deepa Mandal, Bikash Ranjan Sahu, Tithi Parija

Original Paper

Upregulation of FAM50A promotes cancer development

Mei-Zhen Hu, Zhi-Zheng Dai, Hong-Yu Ji, An-Qi Zheng, Hang Liang, Mei-Mei Shen, Jun-Nan Liu, Kai-Fu Tang, Shu-Juan Zhu, Ke-Jian Wang

Original Paper

Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study

Hassan Hussain Almasoudi, Mohammed Ageeli Hakami, Abdulfattah Y. Alhazmi, Mohammed Makkawi, Sultan Alasmari, Youssef Saeed Alghamdi, Mutaib M. Mashraqi

Original Paper

Exosomal PIK3CB promotes PD-L1 expression and malignant transformation in esophageal squamous cell carcinoma

Wei Xu, Yang Chen, Zhi Zhang, Yuequan Jiang, Zhiqiang Wang

Original Paper

Hub gene of disulfidptosis-related immune checkpoints in breast cancer

Ye Wang, Yinmei Deng, Hui Xie, Sujuan Cao

Original Paper

The antagonistic effects of temozolomide and trichostatin a combination on MGMT and DNA mismatch repair pathways in Glioblastoma

Mustafa Güven, Filiz Taşpınar, Farika Nur Denizler-Ebiri, Javier S Castresana, Mehmet Taşpınar

Original Paper

A novel TREM1/DAP12-based multiple chain CAR-T cell targets PTK7 in ovarian cancer therapy

Tongpeng Xu, Chen Wang, Xiaoyan Wang, Enxiu Wang, Bo Wang, Ming Sun

Original Paper

Proliferation inhibition and apoptosis of liver cancer cells treated by blue light irradiation

Yun Teng, Zhige Li, Junsong Liu, Lesheng Teng, Hongdong Li

Original Paper

Fucoxanthin triggers ferroptosis in glioblastoma cells by stabilizing the transferrin receptor

Qin Zhu, Yanqing Zhou, Haixia Wang, Tao Cao, Xinzhi Wang, Rui Liu, Hao Wu, Binyan Lin

Original Paper

Auraptene-induced cytotoxic effects in acute myeloid leukemia cell lines

Majid Ghorbani, Mohammad Soukhtanloo, Amir Salek Farrokhi, Seyed Mahdi Hassanian, Fatemeh Ghorbani, Amir Reza Afshari, Mohsen Taherian, Mohammad Hadi Sadeghian

Original Paper

Preliminary study on the mechanism of POFUT1 in colorectal cancer

Nianfeng Zhang, Linna Long, Guang Li, Xingang Wu, Shubin Peng, Yu Jiang, Anping Xiang, Xianhua Mao, He Huang, Zhiying Yang

Original Paper

PDGF-BB/PDGFRβ induces tumour angiogenesis via enhancing PKM2 mediated by the PI3K/AKT pathway in Wilms’ tumour

Bo-tao Sang, Chang-dong Wang, Xing Liu, Jia-qi Guo, Jia-yi Lai, Xiang-mei Wu

Original Paper

Proapoptotic and proautophagy effect of H1-receptor antagonist desloratadine in human glioblastoma cell lines

Sasenka Vidicevic-Novakovic, Zeljka Stanojevic, Nina Tomonjic, Katarina Karapandza, Janko Zekovic, Tamara Martinovic, Danica Grujicic, Rosanda Ilic, Savo Raicevic, Jelena Tasic, Aleksandra Isakovic

Original Paper

Inhibition of FEN1 promotes DNA damage and enhances chemotherapeutic response in prostate cancer cells

Zhouyuan Wang, Chenxuan Yong, Yulian Fu, Yuling Sun, Zhigang Guo, Song-Bai Liu, Zhigang Hu

Review Article

HPV-associated cancers: insights into the mechanistic scenario and latest updates

Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Rama Jayaraj, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Sabina Evan Prince, Balachandar Vellingiri, Abhijit Dey, Kaviyarasi Renu

Review Article

The evolving landscape of involvement of DTYMK enzymes in cancer

Nadia Heydari, Mahsa Mahdizadeh, Seyyed Mehdi Jafari

Review Article

Recent advances in understanding brain cancer metabolomics: a review

Anirban Goutam Mukherjee, Abilash Valsala Gopalakrishnan, Rama Jayaraj, Raja Ganesan, Kaviyarasi Renu, Balachandar Vellingiri, Abhijit Dey, Mohamudha Parveen

Review Article

Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer

Adriana Stuardo-Parada, Rodrigo López-Muñoz, Franz Villarroel-Espindola, Carlos D. Figueroa, Pamela Ehrenfeld

Open Access Review Article

Impact of exosome therapy on pancreatic cancer and its progression

Mohamed El-Tanani, Hamdi Nsairat, Ismail I. Matalka, Alaa A. A. Aljabali, Vijay Mishra, Yachana Mishra, Gowhar A. Naikoo, Sai Raghuveer Chava, Nitin B. Charbe, Murtaza M. Tambuwala

Review Article

The recent insight in the release of anticancer drug loaded into PLGA microspheres

Farzad Rahmani, Saghi Naderpour, Behnam Ghorbani Nejad, Milad Rahimzadegan, Zivar Nejad Ebrahimi, Hossein Kamali, Rahim Nosrati

Open Access Review Article

Spontaneous tumor lysis syndrome in patients with solid tumors: a scoping review of the literature

Michail Papapanou, Anastasios E. Athanasopoulos, Eleni Georgiadi, Stefanos A. Maragkos, Michalis Liontos, Dimitrios C. Ziogas, Dimitrios Damaskos, Dimitrios Schizas

Review Article

TRAIL-mediated signaling in bladder cancer: realization of clinical efficacy of TRAIL-based therapeutics in medical oncology

Ammad Ahmad Farooqi, Rakhmetova Venera, Gulnara Kapanova, Gulnur Tanbayeva, Gulshara Akhmetova, Yerlan Kudabayev, Assiya Turgambayeva

Review Article

Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment

Harshini Swaminathan, K. Saravanamurali, Sangilimuthu Alagar Yadav

Review Article

Immune checkpoint inhibitors promising role in cancer therapy: clinical evidence and immune-related adverse events

Seyed Mohammadmahdi Meybodi, Bahareh Farasati Far, Ali Pourmolaei, Farid Baradarbarjastehbaf, Maryam Safaei, Niloufar Mohammadkhani, Ali Akbar Samadani

Review Article

Oncolytic viruses against cancer, promising or delusion?

Arash Letafati, Omid Salahi Ardekani, Mina Naderisemiromi, Mohammad Mehdi Fazeli, Nillofar Asadi Jemezghani, Jila Yavarian

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.